FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018171683> ?p ?o ?g. }

• W2018171683 endingPage "G1210" @default.
• W2018171683 startingPage "G1202" @default.
• W2018171683 abstract "Glucagon-like peptide 2 (GLP-2) is an important intestinal growth factor with anti-inflammatory activity. We hypothesized that GLP-2 decreases mucosal inflammation and the associated increased epithelial proliferation by downregulation of Th1 cytokines attributable to reprogramming of lamina propria immune regulatory cells via an interleukin-10 (IL-10)-independent pathway. The effects of GLP-2 treatment were studied using the IL-10-deficient (IL-10(-/-)) mouse model of colitis. Wild-type and IL-10(-/-) mice received saline or GLP-2 (50 microg/kg sc) treatment for 5 days. GLP-2 treatment resulted in significant amelioration of animal weight loss and reduced intestinal inflammation as assessed by histopathology and myeloperoxidase levels compared with saline-treated animals. In colitis animals, GLP-2 treatment also reduced crypt cell proliferation and crypt cell apoptosis. Proinflammatory (IL-1beta, TNF-alpha, IFN-gamma,) cytokine protein levels were significantly reduced after GLP-2 treatment, whereas IL-4 was significantly increased and IL-6 production was unchanged. Fluorescence-activated cell sorting analysis of lamina propria cells demonstrated a decrease in the CD4(+) T cell population following GLP-2 treatment in colitic mice and an increase in CD11b(+)/F4/80(+) macrophages but no change in CD25(+)FoxP3 T cells or CD11c(+) dendritic cells. In colitis animals, intracellular cytokine analysis demonstrated that GLP-2 decreased lamina propria macrophage TNF-alpha production but increased IGF-1 production, whereas transforming growth factor-beta was unchanged. GLP-2-mediated reduction of crypt cell proliferation was associated with an increase in intestinal epithelial cell suppressor of cytokine signaling (SOCS)-3 expression and reduced STAT-3 signaling. This study shows that the anti-inflammatory effects of GLP-2 are IL-10 independent and that GLP-2 alters the mucosal response of inflamed intestinal epithelial cells and macrophages. In addition, the suggested mechanism of the reduction in inflammation-induced proliferation is attributable to GLP-2 activation of the SOCS-3 pathway, which antagonizes the IL-6-mediated increase in STAT-3 signaling." @default.
• W2018171683 created "2016-06-24" @default.
• W2018171683 creator A5027324463 @default.
• W2018171683 creator A5032640413 @default.
• W2018171683 creator A5056346068 @default.
• W2018171683 creator A5079483803 @default.
• W2018171683 date "2008-12-01" @default.
• W2018171683 modified "2023-10-15" @default.
• W2018171683 title "Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2" @default.
• W2018171683 cites W144558062 @default.
• W2018171683 cites W1592779488 @default.
• W2018171683 cites W1595975240 @default.
• W2018171683 cites W1708330158 @default.
• W2018171683 cites W1966064580 @default.
• W2018171683 cites W1979351468 @default.
• W2018171683 cites W1984127959 @default.
• W2018171683 cites W1988568845 @default.
• W2018171683 cites W1991218492 @default.
• W2018171683 cites W1991912061 @default.
• W2018171683 cites W1994859327 @default.
• W2018171683 cites W2002764863 @default.
• W2018171683 cites W2006578936 @default.
• W2018171683 cites W2013264917 @default.
• W2018171683 cites W2013395086 @default.
• W2018171683 cites W2032999541 @default.
• W2018171683 cites W2043325303 @default.
• W2018171683 cites W2055834679 @default.
• W2018171683 cites W2061264646 @default.
• W2018171683 cites W2100093779 @default.
• W2018171683 cites W2101365364 @default.
• W2018171683 cites W2102074325 @default.
• W2018171683 cites W2110179176 @default.
• W2018171683 cites W2110584203 @default.
• W2018171683 cites W2124272026 @default.
• W2018171683 cites W2128444087 @default.
• W2018171683 cites W2130358771 @default.
• W2018171683 cites W2136938818 @default.
• W2018171683 cites W2147495692 @default.
• W2018171683 cites W2150176853 @default.
• W2018171683 cites W2153577424 @default.
• W2018171683 cites W2157621651 @default.
• W2018171683 cites W2160218747 @default.
• W2018171683 cites W2162542603 @default.
• W2018171683 cites W2282727073 @default.
• W2018171683 cites W2342065462 @default.
• W2018171683 cites W4234615218 @default.
• W2018171683 doi "https://doi.org/10.1152/ajpgi.90494.2008" @default.
• W2018171683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18845573" @default.
• W2018171683 hasPublicationYear "2008" @default.
• W2018171683 type Work @default.
• W2018171683 sameAs 2018171683 @default.
• W2018171683 citedByCount "84" @default.
• W2018171683 countsByYear W20181716832012 @default.
• W2018171683 countsByYear W20181716832013 @default.
• W2018171683 countsByYear W20181716832014 @default.
• W2018171683 countsByYear W20181716832015 @default.
• W2018171683 countsByYear W20181716832016 @default.
• W2018171683 countsByYear W20181716832017 @default.
• W2018171683 countsByYear W20181716832018 @default.
• W2018171683 countsByYear W20181716832019 @default.
• W2018171683 countsByYear W20181716832020 @default.
• W2018171683 countsByYear W20181716832021 @default.
• W2018171683 countsByYear W20181716832022 @default.
• W2018171683 countsByYear W20181716832023 @default.
• W2018171683 crossrefType "journal-article" @default.
• W2018171683 hasAuthorship W2018171683A5027324463 @default.
• W2018171683 hasAuthorship W2018171683A5032640413 @default.
• W2018171683 hasAuthorship W2018171683A5056346068 @default.
• W2018171683 hasAuthorship W2018171683A5079483803 @default.
• W2018171683 hasConcept C126322002 @default.
• W2018171683 hasConcept C134018914 @default.
• W2018171683 hasConcept C142724271 @default.
• W2018171683 hasConcept C164027704 @default.
• W2018171683 hasConcept C17991360 @default.
• W2018171683 hasConcept C187316574 @default.
• W2018171683 hasConcept C203014093 @default.
• W2018171683 hasConcept C2776914184 @default.
• W2018171683 hasConcept C2777310793 @default.
• W2018171683 hasConcept C2778690821 @default.
• W2018171683 hasConcept C2779281246 @default.
• W2018171683 hasConcept C2779727006 @default.
• W2018171683 hasConcept C2781219945 @default.
• W2018171683 hasConcept C2908647359 @default.
• W2018171683 hasConcept C529295009 @default.
• W2018171683 hasConcept C55493867 @default.
• W2018171683 hasConcept C71924100 @default.
• W2018171683 hasConcept C74172505 @default.
• W2018171683 hasConcept C86803240 @default.
• W2018171683 hasConcept C8891405 @default.
• W2018171683 hasConcept C99454951 @default.
• W2018171683 hasConceptScore W2018171683C126322002 @default.
• W2018171683 hasConceptScore W2018171683C134018914 @default.
• W2018171683 hasConceptScore W2018171683C142724271 @default.
• W2018171683 hasConceptScore W2018171683C164027704 @default.
• W2018171683 hasConceptScore W2018171683C17991360 @default.
• W2018171683 hasConceptScore W2018171683C187316574 @default.
• W2018171683 hasConceptScore W2018171683C203014093 @default.
• W2018171683 hasConceptScore W2018171683C2776914184 @default.

• next